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be interesting to determine whether 
the transition to a mesenchymal fate 
provides an advantage to cancer 
cells enabling them to escape ento-
sis, or whether entosis is deregulated 
in cancers. As with the initial descrip-
tion of a new phenomenon, which 
often raises more questions than it 
provides answers, defining the pro-
cess of entosis and the genes that 
control it will be needed to establish 
its relevance in vivo.
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Hematopoietic stem cells (HSCs) exist in the bone marrow and circulate in the blood. In this 
issue, Massberg et al. (2007) report that HSCs also travel through the lymphatic system. 
Furthermore, migration of HSCs—which express Toll-like receptors—allows the recogni-
tion of pathogenic molecules in peripheral tissues thereby promoting the local generation 
of innate immune cells at the site of infection.Hematopoietic stem cells (HSCs) 
were once believed to avoid the 
ravages of age by residing in bone 
marrow, where they generate cells 
of nearly all hematopoietic lineages. 
Yet, HSCs are also present in blood 
and other tissues. Studies that mea-
sure the numbers of HSCs in blood 
reveal that nearly all HSCs in the 
bone marrow periodically enter the 
cell cycle (Cheshier et al., 1999; 
Wright et al., 2001). In this issue, 
Massberg, von Andrian, and their 
colleagues chart new patrol routes 
for HSCs, deduce how their migra-
tion is controlled, and establish a 
raison d’être outside of the bone 
marrow (Massberg et al., 2007).
There is recent support for the 
long-held view that HSCs reside in 
association with osteoblasts near 
trabecular bone—the tissue in the 
inner cavities of bones (Adams 842 Cell 131, November 30, 2007 ©2007and Scadden, 2006). This niche is 
thought to represent a nurturing 
environment, providing signals for 
HSC survival, relative quiescence, 
and self renewal (Figure 1). How-
ever, methods for identifying HSCs 
have progressively improved, and 
we now know that larger numbers of 
HSCs can be found in the more cen-
trally located perivascular regions 
of bones (Kiel et al., 2005). Although 
the bone marrow is still considered 
to be the principal site for blood cell 
formation, spleen and liver are also 
important sites for this process dur-
ing fetal development. Moreover, 
blood cell formation in these tis-
sues can be transiently reactivated 
(termed extramedullary hematopoi-
esis) under conditions of unusual 
demand for blood cells such as dur-
ing a parasitic infection or during 
myelofibrosis. Elsevier Inc.Although mobilization of HSCs for 
therapeutic transplantation is being 
extensively studied (Winkler and 
Levesque, 2006), mechanisms associ-
ated with normal egress into the circu-
lation are poorly understood. It is likely 
that cell adhesion molecules, proadhe-
sive chemokines, crowding, neutrophil-
derived proteases, and innervation of 
niches by the sympathetic nervous sys-
tem all determine whether HSCs remain 
sessile or are induced to migrate. The 
blood of a mouse contains between 
100 and 400 HSCs at any one time, 
but they reside there for only seconds, 
and some eventually return to the bone 
marrow (Wright et al., 2001). Thus, there 
may be continual low-level exchange of 
HSCs between hematopoietic niches 
in different bones. Many studies sug-
gest that export of stem and progenitor 
cells from bone marrow can increase 
dramatically during infection.
figure 1. Migration of Hematopoietic stem and Progenitor cells
(1) Many stem cells reside in association with osteoblasts in trabecular bone. (2) An even greater 
number are close to centrally located vascular sinuses, but little is known about exchange between 
these two locations. (3) Pathogen products and cytokines released during infection can mobilize 
hematopoietic stem and progenitor cells (HSPCs), which migrate out of the marrow into blood, but 
small numbers exit under normal circumstances. HSPCs remain in the circulation for only seconds 
but reside in tissues such as the lungs, liver, and spleen for at least 36 hr. (4) Their stay is extended 
by recognition of microbial or viral products by the Toll-like receptors (TLR) that they express. Den-
dritic and myeloid cells are produced locally from HSPCs in response to particular TLR ligands, and 
these effectors of the innate immune system presumably fight infections and promote tissue repair. 
(5) Unstimulated HSPCs use their sphingosine-1-phosphate receptors (such as S1P1) to recognize 
steep gradients of sphingosine-1-phosphate and to enter the lymph (blue). (6) HSPCs quickly tran-
sit through one or more lymph nodes before returning to the blood via the thoracic duct. (7) At least 
some stem cells return to marrow niches, but it is not known if they are affected by the journey.Intravenously administered HSCs 
quickly go to the spleen and some re-
enter the blood for transit to a variety 
of tissues (Wright et al., 2001). In the 
new study, von Andrian and colleagues 
(Massberg et al., 2007) now show that 
lymph and lymph nodes represent 
another major migration route for HSCs 
(Figure 1). They demonstrate that HSCs 
reside for a time in nonhematopoietic 
tissues before transiting through the 
lymph nodes, eventually re-entering the 
blood circulation via the thoracic duct. 
Gradients of sphingosine-1-phosphate 
regulate egress of lymphocytes from 
the thymus, spleen, and lymph nodes 
(Pappu et al., 2007). Massberg et al. 
(2007) show that recognition of sphin-
gosine-1-phosphate by receptors on 
the HSCs controls their movement from 
tissues into the lymph. Their work also 
suggests that the route of HSC migra-
tion is different from that of lympho-
cytes. HSCs enter lymph via afferent 
lymphatics rather than high endothelial 
venules and spend little time in lymph nodes before re-entering blood via the 
thoracic duct. Indeed, they even recir-
culate via lymph in mice that lack lymph 
nodes.
All of these findings suggest that 
there is migration of HSCs, but what 
is the purpose? HSC and lineage-
specified progenitors express func-
tional Toll-like receptors (TLRs) (Nagai 
et al., 2006). In humans as well as 
flies, TLRs act as sentinels in cells that 
express them by recognizing foreign 
molecules such as those expressed 
by pathogens. TLR ligands such as 
the bacterial outer membrane com-
ponent lipopolysaccharide promote 
entry of quiescent HSCs into the cell 
cycle, lower the cytokine requirements 
for differentiation of myeloid progeni-
tors, and direct lymphoid progenitors 
to take on a dendritic cell fate (Nagai 
et al., 2006; R.W., R. Pelayo, and P.K., 
unpublished data). Lipopolysaccharide 
injected intravenously quickly finds its 
way to HSCs in the bone marrow. This 
suggests that stem/progenitor cells Cell 131, Novecould be stimulated at that site by cir-
culating pathogen products, resulting 
in generation of more cells of the innate 
immune system. Massberg et al. (2007) 
now show that HSCs can also address 
the threat of infection elsewhere in 
the body. Coinjection of lipopolysac-
charide and HSCs beneath the kidney 
capsule simulated an infection site; this 
TLR ligand encouraged retention of 
hematopoietic cells in peripheral tis-
sues and stimulated their proliferation 
and the preferential generation of den-
dritic cells. These results indicate that 
migration enables HSCs to recognize 
pathogens at infection sites and rapidly 
produce innate immune effector cells.
These exciting observations blur 
the distinction between central ver-
sus peripheral hematopoiesis and 
raise many interesting questions. For 
example, does self renewal of HSCs 
also occur outside the bone marrow, 
or do HSCs expend their expansion 
potential while attempting to counter 
threats? Massberg et al. (2007) dem-
onstrate in vivo what has been previ-
ously observed in culture (Nagai et al., 
2006), that lipopolysaccharide stimu-
lates dendritic cell production. There 
are many functionally specialized 
types of dendritic cells, and recent 
findings suggest that they may have 
different developmental origins (Wu 
and Liu, 2007). Patterns of differentia-
tion depend on location of progenitors 
and exposure to growth and differ-
entiation factors. New observations 
suggest that TLR ligands represent 
additional environmental cues for 
inducing dendritic cell formation, and 
the nature of the dendritic cells pro-
duced depends on which pathogen 
product is involved (Nagai et al., 2006; 
R.W., R. Pelayo, and P.K., unpublished 
data). Fate-mapping models need 
to be developed that can be used to 
trace dendritic cell genealogies under 
normal and disease circumstances.
Given the scarcity of cells involved 
in this study, many of the experiments 
and inferences pertain to myeloid pro-
genitors or to a cell fraction comprising 
HSCs and progenitors together rather 
than to a pure HSC population. Even 
highly purified HSCs are heteroge-
neous, and subsets of HSCs appear to 
be intrinsically biased toward particu-mber 30, 2007 ©2007 Elsevier Inc. 843
lar blood cell lineages (Muller-Sieburg 
and Sieburg, 2006). Could this reflect 
or determine their migration routes?
Pathogen products can recruit addi-
tional HSCs to tissues, but there must 
be antagonistic mechanisms and ways 
to stimulate their self renewal. Other-
wise, chronic infections would exhaust 
our stem cell reserve. HSCs acting as 
scouts in peripheral tissues would not 
be expected to be constrained by mol-
ecules that inhibit their proliferation in 
the bone marrow. Moreover, there are 
age-related increases in HSC numbers 
and skewing of myeloid-to-lymphoid 
differentiation (Rossi et al., 2007). It will 
be interesting to determine whether 
migrating HSCs are particularly sus-
ceptible to aging. The seminal work of 844 Cell 131, November 30, 2007 ©2007
Although there are over 1000 odor-
ant receptor (OR) genes in the mouse 
genome, in any given olfactory sen-
sory neuron, a functional protein 
is stably expressed from only one 
allele of one OR gene (Buck and Axel, 
1991; Chess et al., 1994; Malnic et al., 
1999). What is the mechanism that 
allows a single allele of a single odor-
ant receptor gene to be expressed in 
each olfactory neuron? The large size 
of the OR gene family and the dis-
tribution of family members across 
most chromosomes make it difficult 
to fathom how the precision of this 
exclusivity is achieved. Findings by 
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Complex regulatory mechanis
allele of only one of the 1000 o
provide evidence that regulat
are involved in the singularity Massberg, von Andrian, and their col-
leagues is certain to catalyze further 
exploration of how migration of stem 
cells protects and replaces tissues.
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Nguyen et al. (2007) now suggest that 
elements within the coding region 
itself mediate exclusivity of OR gene 
expression.
Previous work has reported the 
exciting possibility that there is a sin-
gle expression site for OR genes in the 
nucleus, which would help to explain 
the singularity of OR gene expres-
sion (Lomvardas et al., 2006). Chro-
mosome capture and fluorescence 
in situ hybridization (FISH) experi-
ments indicated that a conserved 2 
kb region near an odorant receptor 
cluster on mouse chromosome 14, 
called the H region (Lane et al., 2002; 
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741–750.Serizawa et al., 2003), was physically 
associated with the OR gene cho-
sen for expression irrespective of its 
genomic location (Lomvardas et al., 
2006). This led to the idea that the 
H region was a key regulator of the 
entire OR gene family.
Doubt was cast on this conclu-
sion, however, by experiments 
knocking out the H region in mice 
and demonstrating that numerous 
scattered OR genes maintain seem-
ingly normal expression (Fuss et al., 
2007). In this knockout mouse, it was 
only the nearest OR genes that had 
their expression extinguished. Yet, 
in the 
gion
neral Hospital, Harvard Medical School, 
ach olfactory neuron of one 
his issue, Nguyen et al. (2007) 
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